The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis

被引：0
|
作者：
Jun Li
Shufen Li
Ruifang Chen
Hailin Yu
Xin Lu
机构：
[1] Fudan University,Obstetrics and Gynecology Hospital
[2] Fudan University,Department of Obstetrics and Gynecology of Shanghai Medical College
[3] Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases,Department of Biochemistry and Molecular Biology, Key Laboratory of Molecular Medicine, Ministry of Education
[4] Fudan University Shanghai Medical College,Present address: Department of Gynecology
[5] Obstetrics and Gynecology Hospital of Fudan University,undefined
来源：
Journal of Ovarian Research | / 8卷
关键词：
Ovarian cancer; Anti-angiogenesis therapy; Prognosis; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis
    Tian, Chuan
    Song, Wei
    Tian, Xia
    Sun, Yong
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2018, 48 (05)
  • [32] Clinicopathological and prognostic significance of serum interleukin-8 in ovarian cancer: a meta-analysis
    Dai, Lan
    Xie, Lei
    Liu, Yixuan
    Qiu, Lihua
    Di, Wen
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (01): : 97 - 105
  • [33] Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies
    Xu, Linjuan
    Cai, Jing
    Yang, Qiang
    Ding, Hui
    Wu, Liying
    Li, Tao
    Wang, Zehua
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1257 - 1277
  • [34] Anti-VEGF treatments in epithelial ovarian cancer: Is it only anti-angiogenesis?
    Trinh, X.
    Tjalma, W. A.
    Dirix, L. Y.
    Vermeulen, P. B.
    Van den Eynden, G. G.
    Van Laere, S. J.
    Van der Auwera, I.
    van Dam, P. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [35] ANTI-VEGF treatments in epithelial ovarian cancer: Is it only anti-angiogenesis?
    Trinh, X. B.
    van Dam, P. V.
    Dirix, L. Y.
    Vemeulen, P. B.
    Van Den Eynden, G. G.
    Van Laere, S. J.
    Van Der Auwera, I.
    Tjalma, W. A. A.
    ACTA CLINICA BELGICA, 2008, 63 (02): : 131 - 131
  • [36] Efficacy and safety of anti-angiogenesis medicines for advanced soft tissue sarcoma: a meta-analysis
    Wang, Yuxuan
    Dai, Xiaobo
    Zhu, Yuxi
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (03) : 1536 - 1546
  • [37] Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy
    Gardlik, R.
    Behuliak, M.
    Palffy, R.
    Celec, P.
    Li, C. J.
    GENE THERAPY, 2011, 18 (05) : 425 - 431
  • [38] Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy
    R Gardlik
    M Behuliak
    R Palffy
    P Celec
    C J Li
    Gene Therapy, 2011, 18 : 425 - 431
  • [39] Prognostic significance of tumor angiogenesis in epithelial ovarian cancer
    Obermair, A
    Wasicky, R
    Kaider, A
    Preyer, O
    Lösch, A
    Leodolter, S
    Kölbl, H
    CANCER LETTERS, 1999, 138 (1-2) : 175 - 182
  • [40] The Prognosis of Anti-Angiogenesis Treatments Combined with Standard Therapy for Newly Diagnosed Glioblastoma: A Meta-Analysis of Randomized Controlled Trials
    Li, Yuping
    Hou, Mengzhuo
    Lu, Guangyu
    Ciccone, Natalia
    Wang, Xingdong
    Zhang, Hengzhu
    PLOS ONE, 2016, 11 (12):
12345